Screener
LifeStance Health Group LFST Business Combination Remeasurement Gain Loss On Contingent Consideration
Business Combination Remeasurement Gain Loss On Contingent Consideration at other companies
Other financials
Where this comes from
Reported directly by LifeStance Health Group in its filing.
Tagged under the XBRL concept lfst:BusinessCombinationRemeasurementGainLossOnContingentConsideration.
The source filing: LifeStance Health Group’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338107
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | $404,701 | $348,261 | $785,893 | $679,627 |
| INCOME (LOSS) FROM OPERATIONS | $30,653 | $(2,950) | $52,937 | $(1,346) |
| OTHER EXPENSE | ||||
| Loss on remeasurement of contingent consideration | (26) | — | (31) | — |
| Transaction costs | (445) | — | (989) | — |
| Interest expense, net | (2,632) | (2,900) | (4,425) | (5,973) |
| Other expense | (93) | (92) | (275) | (93) |
| Total other expense | $(3,196) | $(2,992) | $(5,720) | $(6,066) |
Item 1. Financial Statements (Unaudited).
FAQ
- What is LifeStance Health Group's business combination remeasurement gain loss on contingent consideration?
- LifeStance Health Group (LFST) reported business combination remeasurement gain loss on contingent consideration of -$26K in Q2 2026.
- What is the long-term trend for LifeStance Health Group's business combination remeasurement gain loss on contingent consideration?
- Over 2 years (2021 to 2025), LifeStance Health Group's business combination remeasurement gain loss on contingent consideration has grown at a -100.0% compound annual growth rate (CAGR), from -$2.61M to $0.
- What does business combination remeasurement gain loss on contingent consideration mean?
- This reflects the periodic adjustment in the fair value of contingent consideration liabilities related to past acquisitions. It captures the impact of changes in expected earn-out payments based on the performance of acquired practices. Investors use this to assess the accuracy of initial acquisition valuations and the ongoing financial impact of integration performance.
Ask your AI about LifeStance Health Group's business combination remeasurement gain loss on contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude